Last edition
News about "Generic drug exclusivity"
Inventia Healthcare Launches Generic Dapagliflozin in US After FDA Approval
Inventia Healthcare has secured FDA approval for dapagliflozin tablets and begun Day-One commercialisation, expanding access to affordable diabetes and heart failure treatment in the US.
Generic Drug Exclusivity | 09/04/2026 | By News Bureau | 163
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members